乳腺癌的单药及联合非激素化疗 - Suppr

Suppr

超能文献

Single and combination nonhormonal chemotherapy in breast cancer.

作者信息

Carter S K

出版信息

Cancer. 1972 Dec;30(6):1543-55. doi: 10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v.

DOI:10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v

PMID:4565817

Abstract

摘要

相似文献

Single and combination nonhormonal chemotherapy in breast cancer.乳腺癌的单药及联合非激素化疗

Cancer. 1972 Dec;30(6):1543-55. doi: 10.1002/1097-0142(197212)30:6<1543::aid-cncr2820300621>3.0.co;2-v.

Single-agent therapy for Hodgkin's disease.霍奇金淋巴瘤的单药治疗。

Arch Intern Med. 1973 Mar;131(3):377-87.

[Current status of chemotherapy of malignant tumors of the ovaries].[卵巢恶性肿瘤的化疗现状]

Vopr Onkol. 1968;14(6):108-22.

Cytotoxic agents in the treatment of malignant disease.用于治疗恶性疾病的细胞毒性药物。

Br Med J. 1968 Nov 16;4(5628):438-9.

[Effects, administration forms and dosage of cytostatic agents in the treatment of gynecologic tumors. (Review)].

Zentralbl Gynakol. 1967 Sep 23;89(38):1377-83.

Recent developments in chemotherapy of malignancy.恶性肿瘤化疗的最新进展

Laryngoscope. 1975 Mar;85(3):491-8. doi: 10.1288/00005537-197503000-00006.

Chemotherapy of solid tumors. Recent advances.

Postgrad Med. 1976 Feb;59(2):121-6. doi: 10.1080/00325481.1976.11714274.

The chemical therapy of breast cancer.乳腺癌的化学疗法。

Semin Oncol. 1974 Jun;1(2):131-44.

Proceedings: Chemotherapy of adenocarcinoma of the kidney.会议论文：肾腺癌的化疗

Cancer. 1973 Nov;32(5):1062-5. doi: 10.1002/1097-0142(197311)32:5<1062::aid-cncr2820320506>3.0.co;2-u.

[Chemotherapy of cancer. Hints for continuing medical education].

Z Arztl Fortbild (Jena). 1974 Feb 15;68(4):193-5.

引用本文的文献

The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer.光免疫疗法作为一种安全、有效且无毒的治疗浅表性三阴性乳腺癌的治疗选择的治疗潜力。

Cancer Med. 2025 Sep;14(18):e71255. doi: 10.1002/cam4.71255.

Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.低LATS2信使核糖核酸水平可预测乳腺癌患者对表柔比星加环磷酰胺治疗有良好反应，但对多西他赛治疗则不然。

J Cancer Res Clin Oncol. 2007 Aug;133(8):501-9. doi: 10.1007/s00432-007-0194-0. Epub 2007 Feb 13.

CAF versus CAF plus Medroxyprogesterone Acetate for Treatment of Liver Metastases of Breast Cancer.对比醋酸甲羟孕酮联合癌相关成纤维细胞（CAF）与单纯CAF治疗乳腺癌肝转移的疗效

Breast Cancer. 1995 Apr 30;2(1):65-70. doi: 10.1007/BF02966898.

Heat shock proteins and drug resistance.

Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207.

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.阿霉素在体内和体外对肿瘤细胞的细胞毒性。

Br J Cancer. 1980 Dec;42(6):881-9. doi: 10.1038/bjc.1980.336.

The value of prognostic parameters for the stratification of advanced breast cancer patients.晚期乳腺癌患者分层中预后参数的价值。

J Cancer Res Clin Oncol. 1982;102(3):289-99. doi: 10.1007/BF00411349.

Cyclophosphamide-impaired regulation of hepatic heme metabolism.环磷酰胺对肝脏血红素代谢的调节作用受损。

Experientia. 1984 Dec 15;40(12):1390-2. doi: 10.1007/BF01951905.

Chemotherapy of breast cancer.乳腺癌的化疗

Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.

Antitumor efficacy of seventeen anticancer drugs in human breast cancer xenograft (MX-1) transplanted in nude mice.十七种抗癌药物对移植于裸鼠的人乳腺癌异种移植瘤（MX-1）的抗肿瘤疗效。

Cancer Chemother Pharmacol. 1983;10(3):182-6. doi: 10.1007/BF00255758.

In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.蛋白A对环磷酰胺处理大鼠肝微粒体混合功能氧化酶系统的体内保护作用。

Cancer Chemother Pharmacol. 1985;14(2):135-8. doi: 10.1007/BF00434352.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验